Improving tomorrow's care, today.
We develop novel clinical insights, therapeutic targets, diagnostic opportunities, and care process models.
Culmination discovers better health and implements discoveries by partnering with leading technology and biopharmaceutical companies.
The Culmination Intelligence Platform
The Culmination Intelligence Platform
The Intelligence Platform
Our exclusive Culmination Intelligence Platform represents diverse, multi-dimensional, longitudinal clinical data and matched biospecimens. This enriched dataset, including omics-level data, results in an extraordinarily-powerful insight engine for medical research, health data, and health care services.
Longitudinal, Multi-modal
Data
The core component of the Culmination intelligence database is to leverage longitudinal, multi-modal data across the vast de-identified patient data sets to better understand the performance of diagnostics and therapeutics.
Novel
Discovery
Culmination’s intelligence platform includes linked genomic, biological, health, and claims data to yield novel insights.
Omics
Data
Millions of linked biospecimens and associated data in the Culmination Intelligence Platform offer omics-level data generation, including WGS, WTS, WES, proteomics, and other just-in-time omics analyses.
News and Updates
-
![dr-lincoln-naduald-and-president-barak-obama]()
The power of multimodal data
Culmination’s CEO, Dr. Lincoln Nadauld spoke at the Illumina Genomics Forum in San Diego about healthcare innovation.
-
![the-human-genome-mural]()
The path to Culmination's vision
Culmination is changing the world by becoming the trusted source for healthcare insights and discoveries to improve lives.
-
![casey-frankenberger-portrait]()
Introducing our Head of Data
Casey Frankenberger, PhD is Culmination’s SVP, Head of Data, leading the development of our Intelligence Platform.
